Gutartige Lebertumoren – ein Update

Gutartige Lebertumoren werden häufig im Rahmen von Ultraschalluntersuchungen als Zufallsbefund entdeckt. Auch wenn nur selten Komplikationen auftreten bzw. nur in einigen wenigen Fällen die Gefahr einer malignen Transformation besteht, ist eine definitive Diagnose bei allen gutartigen Lebertumoren und tumorartigen Leberläsionen für das weitere Vorgehen von entscheidender Bedeutung.

Schlüsselwörter

benigner Lebertumor - Hämangiom - fokal noduläre Hyperplasie - Leberadenom

• Literatur

• 1 Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014; 109 (09) 1328-1347 quiz 134
• 2 Robert Koch-Institut. Epidemiologisches Bulletin 45/2005. Berlin: Robert Koch-Institut; 2005
• 3 Junghanss T, Da Silva AM, Horton J. et al. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg 2008; 79 (03) 301-311
• 4 European Association for the Study of the Liver (EASL). Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol 2016; 65 (02) 386-398
• 5 Glinkova V, Shevah O, Boaz M. et al. Hepatic haemangiomas: possible association with female sex hormones. Gut 2004; 53 (09) 1352-1355
• 6 Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187 (02) 181-191
• 7 Paradis V, Laurent A, Flejou JF. et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997; 26 (04) 891-895
• 8 Nahm CB, Ng K, Lockie P. et al. Focal nodular hyperplasia – a review of myths and truths. J Gastrointest Surg 2011; 15 (12) 2275-2283
• 9 Belghiti J, Cauchy F, Paradis V. et al. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol 2014; 11 (12) 737-749
• 10 Bunchorntavakul C, Bahirwani R, Drazek D. et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 2011; 34 (06) 664-674
• 11 Zucman-Rossi J, Jeannot E, Nhieu JT. et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43 (03) 515-524
• 12 Védie AL, Sutter O, Ziol M. et al. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018; 5 (01) HEP04
• 13 Nault JC, Paradis V, Cherqui D. et al. Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol 2017; 67 (05) 1074-1083
• 14 Nault JC, Blanc JF, Moga L. et al. Non-invasive diagnosis and follow-up of benign liver tumours. Clin Res Hepatol Gastroenterol 2022; 46 (01) 101765
• 15 Noels JE, van Aalten SM, van der Windt DJ. et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011; 54 (03) 553-558